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Abstract
Background—Colorectal cancer (CRC) screening is recommended for adults aged 50–75 years, 
yet screening rates are low, especially among the uninsured. The CDC initiated the Colorectal 
Cancer Control Program (CRCCP) in 2009 with the goal of increasing CRC screening rates to 
80% by 2014. A total of 29 grantees (states and tribal organizations) receive CRCCP funding to 
(1) screen uninsured adults and (2) promote CRC screening at the population level.
Purpose—CRCCP encourages grantees to use one or more of five evidence-based interventions 
(EBIs) recommended by the Guide to Community Preventive Services. The purpose of the study 
was to evaluate grantees’ EBI use.
Methods—A web-based survey was conducted in 2011 measuring grantees’ use of CRC 
screening EBIs and identifying their implementation partners. Data were analyzed in 2012.
Results—Twenty-eight grantees (97%) completed the survey. Most respondents (96%) used 
small media. Fewer used client reminders (75%); reduction of structural barriers (50%); provider 
reminders (32%); or provider assessment and feedback (50%). Provider-oriented EBIs were rated 
as harder to implement than client-oriented EBIs. Grantees partnered with several types of 
organizations to implement EBIs, many with county- or state-wide reach.
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Conclusions—Almost all grantees implement EBIs to promote CRC screening, but the EBIs 
that may have the greatest impact with CRC screening are implemented by fewer grantees in the 
first 2 years of the CRCCP.
Introduction
Colorectal cancer (CRC) is the second-leading cause of cancer death in the U.S. An 
estimated 143,460 new cases of CRC are expected to occur in 2012, and 51,690 deaths.1 
CRC screening through fecal occult blood or immunochemical tests, flexible 
sigmoidoscopy, or colonoscopy significantly reduces CRC mortality by detecting cancer 
early and prevents CRC by identifying and removing precancerous polyps; it is 
recommended for all adults aged 50–75 years.2–6 CRC screening rates are low in the U.S.; 
65% of adults in this age group report current screening, and rates drop below 40% among 
those without insurance or a medical home.7
The CDC Colorectal Cancer Control Program (CRCCP) awarded a 5-year cooperative 
agreement to 25 states and four tribal organizations for CRC screening in 2009–2010. The 
purpose of the CRCCP is to increase CRC screening rates among all age-eligible adults in 
participating states and tribes to 80% by 2014 and, consequently, to reduce CRC incidence 
and mortality (www.cdc.gov/cancer/crccp/).8 The CRCCP includes two program 
components: (1) CRC screening of low-income, uninsured, and underinsured people 
(screening provision) and (2) increasing population-level screening rates (screening 
promotion). Grantees are strongly encouraged to implement one or more of the five 
evidence-based interventions (EBIs) that are recommended in the Guide to Community 
Preventive Services (Community Guide; www.thecommunityguide.org/cancer/index.html; 
Table 1).9–13 Use of these EBIs resulted in median post-intervention increases of 11%–15% 
in completed CRC screening.9,12,13
The CRCCP’s focus on the entire age-eligible population represents a shift in CDC’s 
approach compared to the National Breast and Cervical Cancer Early Detection Program 
(www.cdc.gov/cancer/nbccedp/about.htm), which focuses on providing screening to 
uninsured and underinsured, low-income women. Therefore, assessing EBI use and 
implementation is necessary to inform potential modifications of the CRCCP operational 
model and future technical assistance for grantees on how to use EBIs. The present study 
was conducted by the Cancer Prevention and Control Research Network, a national network 
funded by CDC and the National Cancer Institute.14 The purpose of this study is to present 
how CRCCP grantees implemented EBIs to promote population-wide CRC screening within 
the first 1–2 years of funding.
Methods
Respondents completed an online survey in Fall 2011; the survey was programmed using 
Qualtrics survey software (www.qualtrics.com). The survey was declared exempt from 
review by the University of Washington and CDC IRBs.
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The questionnaire included questions about use of each of the five Community Guide–
recommended EBIs. For each EBI, respondents were asked whether their CRCCP currently 
uses it, or plans to use it in the next 12 months. Respondents currently using an EBI were 
asked questions about the external partners they are working with and how they are 
implementing the EBIs. Respondents rated the ease of implementing the EBIs and of 
forming their partnerships on 5-point scales (1=very difficult, 5=very easy). Respondents 
provided open-ended responses to questions about facilitators and barriers to implementing 
EBIs and forming partnerships.
Data Analysis
The authors performed descriptive analyses to determine the frequency of CRCCP grantees’ 
use of EBIs, engagement with partners, and mean ratings of “ease of implementing” EBIs 
and forming partnerships. All quantitative analyses were conducted in 2012, using SPSS 
version 18.
Results
The CDC awarded $49,682,917 to the 29 grantees over the first 2 years, with individual 
annual awards ranging from $358,283 to $1,757,615. In all, 28 of the 29 grantees (97%) 
completed the questionnaire. The majority of respondents had been involved with their 
CRCCP for ≥1 year (82%).
Current and Planned Implementation
All but one grantee (96%) reported currently implementing one or more EBI (Table 2). On 
average, the grantees implemented 3.15 EBIs (SD=1.35, range=0–5). Grantees were most 
likely to implement small media (96%) and client reminders (75%) and also rated these as 
easier to implement than the other strategies (Table 2). Several grantees noted in comments 
that off-the-shelf materials and resources such as CDC’s Screen for Life (www.cdc.gov/
screenforlife) and Washington University’s Make It Your Own (MIYO)15 made small media 
and client reminders fairly easy to implement. Many grantees also noted that working with 
providers was difficult given challenges in changing their systems or practice patterns and 
that they are often overburdened and have limited time.
Activities
Most grantees (n=27) distributed multiple types of small media designed to promote CRC 
screening, such as brochures/booklets, flyers, and posters. Electronic media and videos were 
also used by the majority of grantees. Most grantees reported using Screen for Life materials 
and MIYO resources to create small media. All grantees implementing client reminders 
(n=21) reported using mailings (such as postcards, letters, and greeting cards), and over half 
also used telephone, text, and/or e-mail reminders (client reminders could be from 
healthcare providers/clinics, insurers, the public health department). Grantees that reported 
reducing structural barriers to screening (n=14) commonly tried to simplify administrative 
procedures or eliminate obstacles to screening (e.g., by providing transport or reducing 
fees). All of the grantees implementing provider reminders (n=9) used reminders built into 
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the providers’ electronic medical records (EMR) system, and the majority also used patient 
chart reminders.
Partnerships
Most grantees worked with one or more partners (Table 3). Grantees’ roles varied in terms 
of whether the grantee, the primary partner, or both led implementation. Grantees were more 
likely to lead implementation of small media and client reminders; partners were more likely 
to lead reducing structural barriers, provider reminders, and provider assessment and 
feedback interventions. Nearly all of the primary partners’ reach covered at least a single 
county or tribe; most of the primary partners had statewide reach.
Discussion
Nearly all CRCCP grantees used one or more EBI. Overall, more grantees used small media 
and client reminders, and rated these EBIs easier to implement than interventions to reduce 
structural barriers, provider reminders, or provider assessment and feedback, which have 
been shown to have greater impact on improving screening rates than either small media or 
client reminders.13 Given the evidence base for provider reminders and reducing structural 
barriers,16 helping grantees to implement and sustain provider-oriented EBIs may have a 
powerful impact on screening rates.
Limitations and Strengths
The primary limitations of this study are the cross-sectional design and the small number of 
respondents. The small sample size precluded subgroup analyses. The study has several 
strengths, including the unique sample—cancer control programs that were funded to 
promote CRC screening using EBIs—and the exceptional response rate.
Implications for Future Research
Those who receive CRCCP grants provide and promote CRC screening to a diverse group of 
U.S. residents, including those who have the lowest screening rates.7 The ultimate goal of 
using EBIs is to increase CRC screening; future research should examine the intensity with 
which these EBIs were implemented and to what extent CRC screening rates changed, 
especially in groups with low screening rates. Studying factors associated with maintaining 
or abandoning the EBIs will create a catalog of lessons learned that can be shared among 
grantees to help them increase effectiveness in selecting and implementing EBIs.
Conclusion
Those who receive CRCCP grants are implementing EBIs to promote CRC screening, and 
many grantees are planning to implement additional EBIs in the next 12 months. Overall, 
grantees are implementing more client-oriented than provider-oriented strategies; efforts to 
help grantees implement provider-oriented strategies and reduce structural barriers to CRC 
screening may significantly increase screening rates. Studying how CRCCP grantees 
implement EBIs will offer insights for improving both the CRCCP and other programs that 
encourage use of EBIs.
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Table 1
Community Guide evidence-based interventions to increase colorectal cancer screening
Intervention Definition
Client-oriented interventions
Small media Small media include videos and printed materials such as letters, brochures, and newsletters. These materials 
can be used to inform and motivate people to be screened for cancer. They can provide information tailored to 
specific individuals or targeted to general audiences.
Client reminders Client reminders are written (letter, postcard, e-mail) or telephone messages (including automated messages) 
advising people that they are due for screening. Reminder messages may be tailored or untailored.
Reducing structural barriers Structural barriers are noneconomic burdens or obstacles that make it difficult for people to access cancer 
screening. Interventions designed to reduce these barriers may facilitate access to cancer screening services by 
reducing time or distance between service delivery settings and target populations, modifying hours of service 
to meet client needs, offering services in alternative or nonclinical settings, or eliminating or simplifying 
administrative procedures and other obstacles.
Provider-oriented interventions
Reminders and recall systems Reminders inform healthcare providers it is time for a client’s cancer screening test (reminder) or that the 
client is overdue for screening (recall). The reminders can be provided in different ways, such as client charts 
or by e-mail.
Assessment and feedback Provider assessment and feedback interventions both evaluate provider performance in delivering or offering 
screening to clients (assessment) and present providers with information about their performance in providing 
screening services (feedback). Feedback may describe the performance of a group of providers or an 
individual provider, and may be compared with a goal or standard.
Note. Definitions are from www.thecommunityguide.org/cancer/index.html. Recommended interventions are updated based on the latest evidence; 
the interventions measured in this survey include the five interventions recommended to increase colorectal cancer screening at the time the 
CRCCP grantees received funding.
CRCCP, Colorectal Cancer Control Program
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